Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.

about

In vitro production of insulin-responsive skeletal muscle tissue from mouse embryonic stem cells by spermine-induced differentiation method.

P2860

Q52862864-F88DD9C9-D91A-48B0-9AB4-FB71E1CAACAF

P2860

Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.

Item

http://www.wikidata.org/entity/Q39489506

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@en

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@nl

type

Item

label

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@en

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@nl

prefLabel

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@en

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@nl

P1476

Anagliptin increases insulin-i ...... O-dependent mechanism in mice.

@en

P2093

Hiroyuki Sato

http://www.w3.org/2001/XMLSchema#string

Iseki Takamoto

http://www.w3.org/2001/XMLSchema#string

Kaito Iwayama

http://www.w3.org/2001/XMLSchema#string

Kaoru Sugi

http://www.w3.org/2001/XMLSchema#string

Keizo Nakaya

http://www.w3.org/2001/XMLSchema#string

Kumpei Tokuyama

http://www.w3.org/2001/XMLSchema#string

Masao Moroi

http://www.w3.org/2001/XMLSchema#string

Moritaka Goto

http://www.w3.org/2001/XMLSchema#string

Naoto Kubota

http://www.w3.org/2001/XMLSchema#string

Takahito Jomori

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8

Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance

Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment

Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo.

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries

P2888

s00125-016-4071-8

P304

2426-2434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-016-4071-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27525648

http://www.w3.org/2001/XMLSchema#string

P921

glycobiology

Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.

about

P2860

P2860

Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921